You Are Here: Home » Blog » Structure-based design used as tool for engineering deimmunized biotherapeutics

Structure-based design used as tool for engineering deimmunized biotherapeutics




In the first experimental use of algorithms that employ structure-based molecular modeling to optimize deimmunized drug candidates, Karl Griswold, PhD, and co-investigator Christopher Bailey-Kellogg, PhD of Dartmouth College complement their prior sequence-based deimmunizing algorithms and expand the tool kit of protein engineering technologies to use in next generation drug development.




Read more:
Structure-based design used as tool for engineering deimmunized biotherapeutics

Leave a Comment

You must be logged in to post a comment.

Read previous post:
Researchers gain better understanding of cellular intestinal barrier structure

(Phys.org)—A team of researches affiliated with several institutions in Japan has conducted research into the cellular structure of tight junctions...

Close
Scroll to top